Shimpei Fujimoto
Nankoku, 7838505, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 55 publications
AgRP reflects glucocorticoid action: integrated experimental and clinical evidence.
Journal: Endocrine
Published: April 20, 2026
Clinical Utility of Gait Speed Indices for Identifying Sarcopenia in Older Adults with Type 2 Diabetes.
Journal: Geriatrics (Basel, Switzerland)
Published: February 26, 2026
Hypopituitarism due to CNS Aspergillus Infection.
Journal: Internal medicine (Tokyo, Japan)
Published: March 10, 2024
Clinical significance of amphiregulin in patients with chronic kidney disease.
Journal: Clinical and experimental nephrology
Published: May 26, 2023
What is the optimal range of glycemic control for non-diabetic patients undergoing gastroenterological surgery? A single-center randomized controlled trial using an artificial pancreas.
Journal: Artificial organs
Published: January 28, 2023
Role of Reactive Oxygen Species in Glucose Metabolism Disorder in Diabetic Pancreatic β-Cells.
Journal: Biomolecules
Published: July 21, 2022
Adult-onset Langerhans cell histiocytosis changing CNS lesion from pituitary to suprasellar extension.
Journal: Endocrinology, diabetes & metabolism case reports
Published: May 05, 2022
Knockout of Zeb2 ameliorates progression of renal tubulointerstitial fibrosis in a mouse model of renal ischemia-reperfusion injury.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: June 04, 2021
Unilateral adrenalectomy partially improved hyperglycemia in a patient with primary bilateral macronodular adrenal hyperplasia.
Journal: Diabetology international
Published: February 09, 2021
Correction to: Severe hypoglycemia caused by a small dose of repaglinide and concurrent use of nilotinib and febuxostat in a patient with type 2 diabetes.
Journal: Diabetology international
Published: October 22, 2020
Long-term safety and efficacy of alogliptin, a DPP-4 inhibitor, in patients with type 2 diabetes: a 3-year prospective, controlled, observational study (J-BRAND Registry).
Journal: BMJ open diabetes research & care
Published: July 23, 2020
Last Updated: 09/26/2026